CG Oncology, Inc. SEC filings CGON
CG Oncology, Inc. has 243 filings in SEC EDGAR's recent list, going back to Oct 27, 2023. Its latest annual report, Form ARS, was filed on Apr 24, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 6, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 6, 2026 (results of operations, other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 4 | Insider transaction | Oct 19, 2026 | Oct 15, 2026 |
| 4 | Insider transaction | Oct 19, 2026 | Oct 15, 2026 |
| 3 | Initial insider ownership | Oct 19, 2026 | Oct 13, 2026 |
| 144 | Notice of proposed sale | Oct 15, 2026 | — |
| 144 | Notice of proposed sale | Sep 21, 2026 | — |
| 144 | Notice of proposed sale | Sep 17, 2026 | — |
| 4 | Insider transaction | Sep 17, 2026 | Sep 15, 2026 |
| 144 | Notice of proposed sale | Sep 11, 2026 | — |
| 144 | Notice of proposed sale | Sep 2, 2026 | — |
| 144 | Notice of proposed sale | Aug 31, 2026 | — |
| 144 | Notice of proposed sale | Aug 27, 2026 | — |
| 144 | Notice of proposed sale | Aug 25, 2026 | — |
| 144 | Notice of proposed sale | Aug 24, 2026 | — |
| 144 | Notice of proposed sale | Aug 19, 2026 | — |
| 4 | Insider transaction | Aug 18, 2026 | Aug 14, 2026 |
| 144 | Notice of proposed sale | Aug 17, 2026 | — |
| 144 | Notice of proposed sale | Aug 14, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2026 | — |
| 144 | Notice of proposed sale | Aug 13, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 13, 2026 | — |
| 144 | Notice of proposed sale | Aug 12, 2026 | — |
| 144 | Notice of proposed sale | Aug 11, 2026 | — |
| 144 | Notice of proposed sale | Aug 10, 2026 | — |
| 144 | Notice of proposed sale | Aug 7, 2026 | — |
| 144 | Notice of proposed sale | Aug 6, 2026 | — |
| 10-Q | Quarterly report | Aug 6, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations, Other events
|
Aug 6, 2026 | Aug 6, 2026 |
| 424B5 | Prospectus supplement | Aug 6, 2026 | — |
| 144 | Notice of proposed sale | Aug 5, 2026 | — |
| 144 | Notice of proposed sale | Jul 29, 2026 | — |
| 144 | Notice of proposed sale | Jul 28, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jul 27, 2026 | — |
| 144 | Notice of proposed sale | Jul 27, 2026 | — |
| 144 | Notice of proposed sale | Jul 23, 2026 | — |
| 4 | Insider transaction | Jul 17, 2026 | Jul 15, 2026 |
| 144 | Notice of proposed sale | Jul 15, 2026 | — |
| 4 | Insider transaction | Jul 14, 2026 | Jul 10, 2026 |
| 144 | Notice of proposed sale | Jul 10, 2026 | — |
| 144 | Notice of proposed sale | Jul 1, 2026 | — |
| 4 | Insider transaction | Jun 29, 2026 | Jun 25, 2026 |
| 4 | Insider transaction | Jun 25, 2026 | Jun 24, 2026 |
| 144 | Notice of proposed sale | Jun 24, 2026 | — |
| 4 | Insider transaction | Jun 23, 2026 | Jun 22, 2026 |
| 144 | Notice of proposed sale | Jun 22, 2026 | — |
| 4 | Insider transaction | Jun 16, 2026 | Jun 15, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 8, 2026 | Jun 4, 2026 |
| 4 | Insider transaction | Jun 5, 2026 | Jun 4, 2026 |
| 4 | Insider transaction | Jun 5, 2026 | Jun 4, 2026 |
| 4 | Insider transaction | Jun 5, 2026 | Jun 4, 2026 |
| 4 | Insider transaction | Jun 5, 2026 | Jun 4, 2026 |
| 4 | Insider transaction | Jun 5, 2026 | Jun 4, 2026 |
| 4 | Insider transaction | Jun 5, 2026 | Jun 4, 2026 |
| 144 | Notice of proposed sale | Jun 4, 2026 | — |
| 8-K |
Current report
Officer or director change
|
May 26, 2026 | May 20, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | May 15, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | May 15, 2026 | — |
| 10-Q | Quarterly report | May 8, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations
|
May 8, 2026 | May 8, 2026 |
| ARS | Annual report to shareholders | Apr 24, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Apr 24, 2026 | — |
| DEF 14A | Proxy statement | Apr 24, 2026 | Apr 23, 2026 |
| 4 | Insider transaction | Apr 20, 2026 | Apr 17, 2026 |
| 144 | Notice of proposed sale | Apr 17, 2026 | — |
| 4 | Insider transaction | Apr 16, 2026 | Apr 15, 2026 |
| 4 | Insider transaction | Apr 16, 2026 | Apr 15, 2026 |
| 4 | Insider transaction | Apr 16, 2026 | Apr 15, 2026 |
| 4 | Insider transaction | Apr 16, 2026 | Apr 15, 2026 |
| 4 | Insider transaction | Apr 16, 2026 | Apr 15, 2026 |
| 8-K |
Current report
Officer or director change
|
Apr 13, 2026 | Apr 13, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Mar 26, 2026 | — |
| 4 | Insider transaction | Mar 17, 2026 | Mar 16, 2026 |
| 4 | Insider transaction | Mar 13, 2026 | Mar 12, 2026 |
| 4 | Insider transaction | Mar 6, 2026 | Mar 4, 2026 |
| S-8 | Employee stock plan registration | Feb 27, 2026 | — |
| 10-K | Annual report | Feb 27, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations
|
Feb 27, 2026 | Feb 27, 2026 |
| 8-K |
Current report
Other events
|
Jan 13, 2026 | Jan 13, 2026 |
| 424B5 | Prospectus supplement | Jan 13, 2026 | — |
| 4 | Insider transaction | Jan 13, 2026 | Jan 9, 2026 |
| 144 | Notice of proposed sale | Jan 9, 2026 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jan 9, 2026 | Jan 9, 2026 |
| 4 | Insider transaction | Nov 26, 2025 | Nov 24, 2025 |
| 3 | Initial insider ownership | Nov 26, 2025 | Nov 24, 2025 |
| 8-K |
Current report
Officer or director change
|
Nov 26, 2025 | Nov 22, 2025 |
| 3 | Initial insider ownership | Nov 24, 2025 | Nov 17, 2025 |
| 4 | Insider transaction | Nov 18, 2025 | Nov 17, 2025 |
| 8-K |
Current report
Officer or director change
|
Nov 14, 2025 | Nov 10, 2025 |
| 10-Q | Quarterly report | Nov 14, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 14, 2025 | Nov 14, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | Nov 12, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Oct 30, 2025 | — |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Oct 28, 2025 | — |
| 4 | Insider transaction | Oct 15, 2025 | Oct 13, 2025 |
| 4 | Insider transaction | Oct 10, 2025 | Oct 9, 2025 |
| 144 | Notice of proposed sale | Oct 9, 2025 | — |
| 4 | Insider transaction | Oct 1, 2025 | Sep 30, 2025 |
| 4 | Insider transaction | Sep 30, 2025 | Sep 29, 2025 |
| 144 | Notice of proposed sale | Sep 30, 2025 | — |
| 4 | Insider transaction | Sep 22, 2025 | Sep 18, 2025 |
| SCHEDULE 13D | Ownership over 5% (active) | Sep 18, 2025 | — |
| SCHEDULE 13D | Ownership over 5% (active) | Sep 18, 2025 | — |
| 144 | Notice of proposed sale | Sep 18, 2025 | — |
| 4 | Insider transaction | Sep 16, 2025 | Sep 15, 2025 |
| 144 | Notice of proposed sale | Sep 15, 2025 | — |
| 4 | Insider transaction | Sep 15, 2025 | Sep 11, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 9, 2025 | Sep 9, 2025 |
| 4 | Insider transaction | Sep 8, 2025 | Sep 5, 2025 |
| 144 | Notice of proposed sale | Sep 5, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Sep 5, 2025 | Sep 5, 2025 |
| 4 | Insider transaction | Sep 4, 2025 | Sep 3, 2025 |
| 4 | Insider transaction | Sep 4, 2025 | Sep 3, 2025 |
| 144 | Notice of proposed sale | Sep 3, 2025 | — |
| 144 | Notice of proposed sale | Sep 3, 2025 | — |
| 10-Q | Quarterly report | Aug 8, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 8, 2025 | Aug 8, 2025 |
| 3 | Initial insider ownership | Aug 6, 2025 | Aug 5, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | Aug 6, 2025 | — |
| 4 | Insider transaction | Jul 18, 2025 | Jul 17, 2025 |
| 144 | Notice of proposed sale | Jul 17, 2025 | — |
| 8-K |
Current report
Officer or director change
|
Jul 11, 2025 | Jul 7, 2025 |
| 4 | Insider transaction | Jun 6, 2025 | Jun 5, 2025 |
| 4 | Insider transaction | Jun 6, 2025 | Jun 5, 2025 |
| 4 | Insider transaction | Jun 6, 2025 | Jun 5, 2025 |
| 4 | Insider transaction | Jun 6, 2025 | Jun 5, 2025 |
| 4 | Insider transaction | Jun 6, 2025 | Jun 5, 2025 |
| 4 | Insider transaction | Jun 6, 2025 | Jun 5, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Jun 6, 2025 | Jun 5, 2025 |
| 4 | Insider transaction | May 22, 2025 | May 21, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2025 | — |
| 10-Q | Quarterly report | May 13, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations
|
May 13, 2025 | May 13, 2025 |
| 4 | Insider transaction | Apr 29, 2025 | Apr 28, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Apr 28, 2025 | Apr 26, 2025 |
| ARS | Annual report to shareholders | Apr 25, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | Apr 25, 2025 | — |
| DEF 14A | Proxy statement | Apr 25, 2025 | Jun 5, 2025 |
| 4 | Insider transaction | Apr 16, 2025 | Apr 15, 2025 |
| 4 | Insider transaction | Apr 16, 2025 | Apr 15, 2025 |
| 4 | Insider transaction | Apr 16, 2025 | Apr 15, 2025 |
| 4 | Insider transaction | Apr 16, 2025 | Apr 15, 2025 |
| 4 | Insider transaction | Apr 16, 2025 | Apr 15, 2025 |
| S-3ASR | Automatic shelf registration | Mar 28, 2025 | — |
| 10-K | Annual report | Mar 28, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations
|
Mar 28, 2025 | Mar 28, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Mar 24, 2025 | Mar 24, 2025 |
| 4 | Insider transaction | Mar 18, 2025 | Mar 17, 2025 |
| 144 | Notice of proposed sale | Mar 17, 2025 | — |
| 4 | Insider transaction | Feb 19, 2025 | Feb 18, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 14, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jan 28, 2025 | — |
| 4 | Insider transaction | Jan 14, 2025 | Jan 13, 2025 |
| 8-K |
Current report
Officer or director change
|
Jan 10, 2025 | Jan 9, 2025 |
| 4 | Insider transaction | Dec 17, 2024 | Dec 16, 2024 |
| 4 | Insider transaction | Dec 17, 2024 | Dec 16, 2024 |
| 424B4 | Prospectus | Dec 13, 2024 | — |
| EFFECT | Filing | Dec 12, 2024 | — |
| S-1/A | Amended registration statement | Dec 11, 2024 | — |
| CORRESP | Letter to the SEC | Dec 11, 2024 | — |
| CORRESP | Letter to the SEC | Dec 11, 2024 | — |
| S-1 | Registration statement | Dec 11, 2024 | — |
| 4 | Insider transaction | Dec 6, 2024 | Dec 6, 2024 |
| 144 | Notice of proposed sale | Dec 6, 2024 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Dec 5, 2024 | Dec 5, 2024 |
| UPLOAD | Letter from the SEC | Nov 21, 2024 | — |
| DRS | Filing | Nov 14, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 12, 2024 | — |
| 10-Q | Quarterly report | Nov 12, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 12, 2024 | Nov 12, 2024 |
| SC 13G | Ownership over 5% (passive) | Nov 8, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 4, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Oct 22, 2024 | — |
| 4 | Insider transaction | Oct 8, 2024 | Oct 4, 2024 |
| 4 | Insider transaction | Oct 7, 2024 | Oct 4, 2024 |
| 4 | Insider transaction | Oct 7, 2024 | Oct 4, 2024 |
| 4 | Insider transaction | Oct 7, 2024 | Oct 4, 2024 |
| 4 | Insider transaction | Oct 7, 2024 | Oct 4, 2024 |
| 4 | Insider transaction | Oct 7, 2024 | Oct 4, 2024 |
| 4 | Insider transaction | Oct 7, 2024 | Oct 4, 2024 |
| 4 | Insider transaction | Oct 7, 2024 | Oct 4, 2024 |
| 4 | Insider transaction | Oct 7, 2024 | Oct 4, 2024 |
| 4 | Insider transaction | Oct 7, 2024 | Oct 4, 2024 |
| 4 | Insider transaction | Oct 7, 2024 | Oct 4, 2024 |
| 4 | Insider transaction | Aug 30, 2024 | Aug 29, 2024 |
| 144 | Notice of proposed sale | Aug 29, 2024 | — |
| 144 | Notice of proposed sale | Aug 29, 2024 | — |
| 144 | Notice of proposed sale | Aug 29, 2024 | — |
| 144 | Notice of proposed sale | Aug 29, 2024 | — |
| 10-Q | Quarterly report | Aug 8, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 8, 2024 | Aug 8, 2024 |
| SC 13G | Ownership over 5% (passive) | Jul 22, 2024 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
May 24, 2024 | May 24, 2024 |
| 4 | Insider transaction | May 16, 2024 | May 15, 2024 |
| 3 | Initial insider ownership | May 16, 2024 | May 13, 2024 |
| 8-K |
Current report
Results of operations
|
May 9, 2024 | May 9, 2024 |
| 10-Q | Quarterly report | May 9, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Other events
|
May 3, 2024 | May 3, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Apr 9, 2024 | — |
| 4/A | Filing | Apr 9, 2024 | Jan 29, 2024 |
| 10-K | Annual report | Mar 26, 2024 | Dec 31, 2023 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- CGON (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Dallas, TX
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1991792
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.